Literature DB >> 23018914

Echocardiographic abnormalities in patients with COPD at their first hospital admission.

Xavier Freixa1, Karina Portillo, Carles Paré, Judith Garcia-Aymerich, Federico P Gomez, Marta Benet, Josep Roca, Eva Farrero, Jaume Ferrer, Carlos Fernandez-Palomeque, Josep M Antó, Joan Albert Barberà.   

Abstract

Cardiovascular disease accounts for significant morbidity and mortality in chronic obstructive pulmonary disease (COPD). Its prevalence and mechanisms of association have not been elucidated. The study aimed to assess the prevalence of echocardiographic abnormalities and potential risk factors in patients with COPD at their first exacerbation requiring hospital admission. Transthoracic echocardiography was prospectively performed in 342 patients (forced expiratory volume in 1 s 52 ± 16% predicted) 3 months after discharge. Significant cardiac alterations were present in 64% of patients; 27% left- and 48% right-heart disorders. The most common were right ventricle enlargement (30%) and pulmonary hypertension (19%). Left ventricle enlargement was present in 6%, left ventricle systolic dysfunction in 13%, left ventricle diastolic impairment in 12% and left atrial dilatation in 29%. Echocardiographic abnormalities were unrelated to COPD severity and were more frequent in patients with self-reported cardiac disease. They were also observed in 63% of patients with no known cardiac disease or cardiovascular risk factors other than smoking. We conclude that cardiac abnormalities are highly prevalent in COPD patients at the time of their first severe exacerbation, even in the absence of established cardiac disease or cardiovascular risk factors. Considering the prognostic and therapeutic implications of cardiac comorbidity, echocardiography should be considered in the assessment of patients with clinically significant COPD.

Entities:  

Mesh:

Year:  2012        PMID: 23018914     DOI: 10.1183/09031936.00222511

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

1.  Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.

Authors:  J Michael Wells; Anand S Iyer; Farbod N Rahaghi; Surya P Bhatt; Himanshu Gupta; Thomas S Denney; Steven G Lloyd; Louis J Dell'Italia; Hrudaya Nath; Raul San Jose Estepar; George R Washko; Mark T Dransfield
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

2.  Rethinking Chronic Obstructive Pulmonary Disease. Chronic Pulmonary Insufficiency and Combined Cardiopulmonary Insufficiency.

Authors:  R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2018-02

Review 3.  Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Authors:  Chad Wade; J Michael Wells
Journal:  Expert Rev Respir Med       Date:  2020-04-19       Impact factor: 3.772

4.  Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.

Authors:  Robert Marcun; Ivan Stankovic; Radosav Vidakovic; Jerneja Farkas; Sasa Kadivec; Biljana Putnikovic; Ivan Ilic; Aleksandar N Neskovic; Mitja Lainscak
Journal:  Intern Emerg Med       Date:  2015-09-30       Impact factor: 3.397

Review 5.  Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

Authors:  Joaquim Gea; Sergi Pascual; Carme Casadevall; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 6.  Effects of cigarette smoke on pulmonary endothelial cells.

Authors:  Qing Lu; Eric Gottlieb; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

7.  Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis.

Authors:  Wei Hua; Wenbo Yang; Jianing Gu; Jialiang Wu; Wei Wang; Yanpu Liu; Hong Zhu; Min Zhou; Jieming Qu; Yuehua Fang
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-14       Impact factor: 2.357

8.  Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study.

Authors:  Dionne E Smid; Sarah Wilke; Paul W Jones; Jean W M Muris; Emiel F M Wouters; Frits M E Franssen; Martijn A Spruit
Journal:  BMJ Open       Date:  2015-07-21       Impact factor: 2.692

9.  Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease.

Authors:  Laura Miranda de Oliveira Caram; Renata Ferrari; Cristiane Roberta Naves; Suzana Erico Tanni; Liana Sousa Coelho; Silméia Garcia Zanati; Marcos Ferreira Minicucci; Irma Godoy
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

10.  Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study.

Authors:  Bianca Beghé; Alessia Verduri; Barbara Bottazzi; Mariarita Stendardo; Alessandro Fucili; Sara Balduzzi; Chiara Leuzzi; Alberto Papi; Alberto Mantovani; Leonardo M Fabbri; Claudio Ceconi; Piera Boschetto
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.